| Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy A Johansson, S Rudolfsson, P Hammarsten, S Halin, K Pietras, J Jones, ... The American journal of pathology 177 (2), 1031-1041, 2010 | 252 | 2010 |
| De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors A Johansson-Percival, B He, ZJ Li, A Kjellén, K Russell, J Li, I Larma, ... Nature immunology 18 (11), 1207-1217, 2017 | 243 | 2017 |
| Tumor-targeted TNFα stabilizes tumor vessels and enhances active immunotherapy A Johansson, J Hamzah, CJ Payne, R Ganss Proceedings of the National Academy of Sciences 109 (20), 7841-7846, 2012 | 189 | 2012 |
| Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer A J: son Lind, P Wikström, T Granfors, L Egevad, P Stattin, A Bergh The Prostate 62 (4), 394-399, 2005 | 97 | 2005 |
| Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules B He, A Jabouille, V Steri, A Johansson‐Percival, IP Michael, ... The Journal of pathology 245 (2), 209-221, 2018 | 87 | 2018 |
| Intratumoral LIGHT restores pericyte contractile properties and vessel integrity A Johansson-Percival, ZJ Li, DD Lakhiani, B He, X Wang, J Hamzah, ... Cell reports 13 (12), 2687-2698, 2015 | 73 | 2015 |
| Remodeling of metastatic vasculature reduces lung colonization and sensitizes overt metastases to immunotherapy B He, A Johansson-Percival, J Backhouse, J Li, GYF Lee, J Hamzah, ... Cell reports 30 (3), 714-724. e5, 2020 | 60 | 2020 |
| Targeting vascular endothelial-cadherin in tumor-associated blood vessels promotes T-cell–mediated immunotherapy Y Zhao, KK Ting, J Li, VC Cogger, J Chen, A Johansson-Percival, ... Cancer Research 77 (16), 4434-4447, 2017 | 59 | 2017 |
| Altered levels of angiopoietin 1 and tie 2 are associated with androgen-regulated vascular regression and growth in the ventral prostate in adult mice and rats A Johansson, SH Rudolfsson, P Wikström, A Bergh Endocrinology 146 (8), 3463-3470, 2005 | 54 | 2005 |
| Immunomodulation of tumor vessels: it takes two to tango A Johansson-Percival, B He, R Ganss Trends in immunology 39 (10), 801-814, 2018 | 50 | 2018 |
| More than a scaffold: stromal modulation of tumor immunity A Johansson, J Hamzah, R Ganss Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1865 (1), 3-13, 2016 | 46 | 2016 |
| Localized expression of angiopoietin 1 and 2 may explain unique characteristics of the rat testicular microvasculature SH Rudolfsson, A Johansson, I Franck Lissbrant, P Wikström, A Bergh Biology of reproduction 69 (4), 1231-1237, 2003 | 32 | 2003 |
| A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model A Johansson, J Jones, K Pietras, S Kilter, Å Skytt, SH Rudolfsson, A Bergh The Prostate 67 (15), 1664-1676, 2007 | 29 | 2007 |
| Therapeutic induction of tertiary lymphoid structures in cancer through stromal remodeling A Johansson-Percival, R Ganss Frontiers in Immunology 12, 674375, 2021 | 28 | 2021 |
| License for destruction: tumor-specific cytokine targeting A Johansson, J Hamzah, R Ganss Trends in molecular medicine 20 (1), 16-24, 2014 | 27 | 2014 |
| Intratumoral TNFα improves immunotherapy A Johansson, J Hamzah, R Ganss Oncoimmunology 1 (8), 1395-1397, 2012 | 14 | 2012 |
| Remodeling of tumor stroma and response to therapy A Johansson, R Ganss Cancers 4 (2), 340-353, 2012 | 13 | 2012 |
| Targeting castration‐induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model A Johansson, SH Rudolfsson, S Kilter, A Bergh BJU international 107 (11), 1818-1824, 2011 | 11 | 2011 |
